MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Prospective observational study on the effects of physical exercise and lifestyle modifications in patients with Parkinson’s disease

    T. Lata (Mumbai, India)

    Objective: This study aimed to assess the effectiveness of physical activity, which includes all movements that increase energy expenditure, in conjunction with exercise, characterized as…
  • 2025 International Congress

    Zonisamide for Motor Symptoms and OFF-Time Reduction in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)

    Objective: To evaluate the efficacy and safety of zonisamide as an adjunct therapy for improving motor function and reducing OFF-time in patients with Parkinson’s disease…
  • 2025 International Congress

    Inpatient Multimodal Care Improves Parkinsonian Symptoms Regardless Of Race Or Ethnicity

    N. Elayan, L. Rubin, M. Mccrossin, A. Di Rocco, M. Ghilardi (New York, USA)

    Objective: To verify demographic characteristics of patients with Parkinson’s disease (PD) completing a two-week inpatient multimodal intensive neurorehabilitation and care (iMINC) program and whether iMINC…
  • 2025 International Congress

    Unraveling the Variability in Amantadine Response for Levodopa-Induced Dyskinesias: The Impact of Clinical and Genetic Factors

    L. Saadatpour, H. Chaparro-Solano, J. Yu, C. Sonneborn, C. Piccinin, S. Anis, E. Assaedi, P. Coss, S. Horn, O. Vaou, I. Mata, H. Fernandez (San Antonio, USA)

    Objective: To identify demographic, clinical, and genetic factors associated with the outcomes of amantadine treatment in dyskinetic Parkinson’s disease (PD) patients. Background: While recent advancements…
  • 2025 International Congress

    Clinical Picture of Acute Akinetic Collapse Leading to Multi-Day Immobility in Parkinson’s Disease

    S. Kobayashi, Y. Hagihara, M. Inoue, J. Nakamura, T. Chiba, K. Hokkoku (Tokyo, Japan)

    Objective: To investigate the clinical characteristics of Parkinson's disease (PD) patients who experienced acute akinesia and immobilization requiring emergency medical care. Background: PD patients sometimes…
  • 2025 International Congress

    Functional Activity of Apomorphine Relative to Dopamine at Dopamine Receptors: Findings from G Protein Coupled Receptor Biosensor Assays

    B. Yegla, P. Jenner, M. Grall, J. Rubin (Rockville, USA)

    Objective: Characterize the functional activity of apomorphine relative to dopamine using a modern panel of G protein-coupled receptor biosensor assays. Background: The structural similarity of…
  • 2025 International Congress

    Efficacy and Safety of IPX203 and Levodopa-Carbidopa Intestinal Gel (LCIG) Compared to Immediate-Release Carbidopa-Levodopa in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    M. Mustafa, A. Abunamoos, Y. Aljazi, F. Alnajjar, A. Sa’D, M. Alghaniem, K. Abuhananeh (Amman, Jordan)

    Objective: To conduct the efficacy and safety of IPX203, an extended-release carbidopa-levodopa formulation, and LCIG, a continuous levodopa infusion, compared to Immediate-Release Carbidopa-Levodopa (IR CD-LD)…
  • 2025 International Congress

    EEG connectivity in Parkinson disease: a comparative analysis of sporadic and genetic forms in ON/OFF therapy.

    M. Treddenti, V. Yahya, S. Marceglia, V. D'Onofrio, A. Guerra, T. Bocci, A. Priori (Milan, Italy)

    Objective: The study aims to compare the connectivity profile of patients affected by sporadic and genetic Parkinson's disease in different levodopa conditions through the analysis…
  • 2025 International Congress

    Stroke, Chronic Ataxia and Tremor in a Pediatric Patient with c.2137C>A Genetic Variant in CACNA1A

    A. Vargas Nino, H. Alfaris, C. Gorodetsky (Toronto, Canada)

    Objective: To describe a pediatric case of chronic non-progressive ataxia, nystagmus, kinetic tremor, refractory epilepsy, and arterial ischemic stroke (AIS) associated with a CACNA1A c.2137C>A…
  • 2025 International Congress

    Patient engagement in Parkinson’s research: Exploring stakeholder perspectives

    J. Bek, N. Simonian, C. Rattan, A. Asis (Dublin, Ireland)

    Objective: The aim of this project was to explore patient engagement in Parkinson’s research in Canada from the perspectives of different stakeholders, and to identify…
  • « Previous Page
  • 1
  • …
  • 315
  • 316
  • 317
  • 318
  • 319
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley